Polen Capital's position in Lilly(Eli) is currently worth $1.04B. That's 6.66% of their entire equity portfolio (3rd largest holding). The first Lilly(Eli) trade was made in Q3 2023. Since then Polen Capital bought shares two more times and sold shares on eight occasions. The stake costed the investor $663M, netting the investor a gain of 57% so far.
Greenwood Capital Associates LLC trimmed its position in Eli Lilly and Company (NYSE: LLY) by 5.6% in the fourth quarter, according to its most recent Form 1...
JM2 Capital Inc. purchased a new position in Eli Lilly and Company (NYSE: LLY) during the undefined quarter, according to the company in its most recent Form...
Coldstream Capital Management Inc. raised its position in Eli Lilly and Company (NYSE: LLY) by 25.6% in the undefined quarter, according to its most recent f...
Core Alternative Capital trimmed its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 10.0% in the third quarter, according to the company in its m...